tiprankstipranks
Akso Health Group Sponsored ADR (AHG)
NASDAQ:AHG
US Market
AHG
Akso Health Group Sponsored ADR
RESEARCH TOOLSreports
Want to see AHG full AI Analyst Report?

Akso Health Group Sponsored ADR (AHG) Ratios

152 Followers

Akso Health Group Sponsored ADR Ratios

AHG's free cash flow for Q4 2025 was $-0.06. For the 2025 fiscal year, AHG's free cash flow was decreased by $ and operating cash flow was $-0.43. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.53 14.20 39.52 1.76 1.24
Quick Ratio
 1.51 14.18 39.46 1.62 1.09
Cash Ratio
 0.93 12.76 23.70 0.68 0.36
Solvency Ratio
 -9.63 -8.41 -2.63 -0.12 -0.33
Operating Cash Flow Ratio
 0.50 0.09 0.38 -0.28 -0.17
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 4.66M$ 180.32M$ 138.42M$ 8.84M$ 12.11M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.00 0.00 0.00
Debt-to-Equity Ratio
 <0.01 <0.01 0.00 0.00 0.00
Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.07 1.08 1.03 2.34 5.11
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 -4.08
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -4.05
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 0.00 0.00 0.12
Net Debt to EBITDA
 8.86 99.34 9.86 0.56 5.79
Profitability Margins
Gross Profit Margin
-6.05%-1.91%5.06%9.63%10.09%
EBIT Margin
-43.12%-26.55%-357.78%-108.23%-53.40%
EBITDA Margin
-15.93%-12.00%-357.78%-108.23%-53.10%
Operating Profit Margin
-2113.36%-1125.37%-357.78%-108.23%-54.34%
Pretax Profit Margin
-2113.27%-1125.14%-376.57%-99.13%-66.80%
Net Profit Margin
-1713.38%-913.38%-391.78%-10.32%-280.83%
Continuous Operations Profit Margin
-2506.45%-916.71%-377.61%-99.26%-68.35%
Net Income Per EBT
81.08%81.18%104.04%10.41%420.37%
EBT Per EBIT
100.00%99.98%105.25%91.59%122.94%
Return on Assets (ROA)
-63.38%-62.79%-6.66%-6.65%-26.83%
Return on Equity (ROE)
-67.58%-67.79%-6.84%-15.59%-137.17%
Return on Capital Employed (ROCE)
-82.87%-82.68%-6.24%-161.40%-26.54%
Return on Invested Capital (ROIC)
-82.85%-67.35%-6.24%-161.40%-26.54%
Return on Tangible Assets
-69.22%-68.78%-6.66%-6.65%-26.83%
Earnings Yield
-18.88%-40.12%-39.86%-50.26%-150.53%
Efficiency Ratios
Receivables Turnover
 1.34 1.15 0.00 1.43 0.30
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 42.89 79.16 11.99 7.06 0.69
Fixed Asset Turnover
 0.04 129.01 0.00 0.00 108.24
Asset Turnover
 0.04 0.07 0.02 0.64 0.10
Working Capital Turnover Ratio
 0.08 0.09 0.03 1.26 0.43
Cash Conversion Cycle
 281.51 323.12 30.45 307.14 1.74K
Days of Sales Outstanding
 273.00 318.51 0.00 255.47 1.22K
Days of Inventory Outstanding
 8.51 4.61 30.45 51.67 527.44
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 281.51 323.12 30.45 307.14 1.74K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 <0.01 0.06 -0.43 -1.30
Free Cash Flow Per Share
 0.02 <0.01 0.06 -0.43 -1.30
CapEx Per Share
 <0.01 <0.01 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 0.87 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 248.08 7.62 0.00 0.00 -1.78K
Capital Expenditure Coverage Ratio
 248.08 7.62 0.00 0.00 -1.78K
Operating Cash Flow Coverage Ratio
 95.54 14.40 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.77 0.08 0.56 -0.25 -1.44
Free Cash Flow Yield
2.96%0.30%5.69%-120.24%-77.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.16 -2.49 -2.51 -1.99 -0.66
Price-to-Sales (P/S) Ratio
 25.18 22.76 9.83 0.21 1.87
Price-to-Book (P/B) Ratio
 3.50 1.69 0.17 0.31 0.91
Price-to-Free Cash Flow (P/FCF) Ratio
 32.92 328.95 17.56 -0.83 -1.30
Price-to-Operating Cash Flow Ratio
 115.10 285.78 17.56 -0.83 -1.30
Price-to-Earnings Growth (PEG) Ratio
 -0.29 -0.37 >-0.01 0.02 >-0.01
Price-to-Fair Value
 3.50 1.69 0.17 0.31 0.91
Enterprise Value Multiple
 -149.23 -90.38 7.11 0.37 2.27
Enterprise Value
 191.66M 160.27M -61.45M -5.22M -7.24M
EV to EBITDA
 -153.40 -90.38 7.11 0.37 2.27
EV to Sales
 24.43 10.85 -25.45 -0.40 -1.21
EV to Free Cash Flow
 31.94 156.71 -45.47 1.60 0.84
EV to Operating Cash Flow
 31.82 136.15 -45.47 1.60 0.84
Tangible Book Value Per Share
 0.54 0.63 6.65 1.16 1.85
Shareholders’ Equity Per Share
 0.60 0.70 6.65 1.14 1.85
Tax and Other Ratios
Effective Tax Rate
 -0.19 0.19 >-0.01 >-0.01 -0.02
Revenue Per Share
 0.02 0.05 0.12 1.73 0.91
Net Income Per Share
 -0.40 -0.47 -0.45 -0.18 -2.54
Tax Burden
 0.81 0.81 1.04 0.10 4.20
Interest Burden
 49.01 42.38 1.05 0.92 1.25
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.07
SG&A to Revenue
 0.37 0.25 3.56 1.18 0.44
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.07
Income Quality
 -0.04 >-0.01 -0.15 0.25 0.51
Currency in USD